Why Do Patients with Type 2 Diabetes Lose Less Weight on GLP-1s? A Mathematical Modeling Analysis

Studied

A mathematical model explored why people with type 2 diabetes may lose less weight during semaglutide treatment.

Who / model

Simulated human energy balance included diabetes-related changes in energy use and glucose lost in urine, with or without background SGLT2-inhibitor treatment. No participant count or simulation duration is stated.

Studied dose & schedule

Dose and schedule have not yet been extracted for this summary.

Found

The model suggested that lower energy use and reduced glucose loss in urine partly explain smaller weight reductions. It predicted the greatest attenuation with background SGLT2 inhibitors. These are model predictions, not a randomized treatment comparison.

Limits

Study limitations were not stated in the abstract. Methodological quality has not been appraised.

Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary